Double blinded, a randomized, double-blinded, control trial shows that onabotulinum toxin A (Botox®) nerve blocks do not provide improved long term pain control compared to control treatments for men with chronic scrotal pain
Main Authors: | J. Dockray, A. Aljumaily, S. Lau, K. Jarvi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320328986 |
Similar Items
-
Characteristics and Etiologies of Chronic Scrotal Pain: A Common but Poorly Understood Condition
by: Aosama Aljumaily, et al.
Published: (2017-01-01) -
Effect of botulinum Toxin-A in myofascial pain in temporomandibular disorders: A randomized, double-blinded, placebo-controlled study
by: Amit Gupta, et al.
Published: (2016-01-01) -
Can acupuncture treatment be double-blinded? An evaluation of double-blind acupuncture treatment of postoperative pain.
by: Lene Vase, et al.
Published: (2015-01-01) -
Postoperative outcomes of intrasphincteric botox injection during hemorrhoidectomy: A double-blind clinical trial
by: Mina Alvandipour, et al.
Published: (2021-01-01) -
The protocol for a multisite, double blind, randomized, placebo-controlled trial of axillary nerve stimulation for chronic shoulder pain
by: Travis Cleland, et al.
Published: (2020-03-01)